Codexis (CDXS) Intangibles (2010 - 2016)
Codexis (CDXS) posted quarterly Intangibles of $281000.0 for Q3 2016, down 92.31% year-over-year from $3.7 million in Q4 2015, and down 75.02% quarter-over-quarter from $1.1 million in Q2 2016.
Codexis (CDXS) Intangibles (2010 - 2016) Analysis & Trends
Codexis' Intangibles history runs 7 years deep, the most recent figure standing at $281000.0 for Q3 2016.
- In Q3 2016, Intangibles fell 92.31% year-over-year to $281000.0; the TTM figure through Sep 2016 stood at $281000.0 (down 92.31% YoY), while the FY2015 annual figure was $2.8 million, down 54.54% from the prior year.
- Intangibles for Q3 2016 stood at $281000.0, down from $1.1 million in the prior quarter.
- The five-year high for Intangibles was $15.5 million in Q1 2012, with the low at $281000.0 in Q3 2016.
- The 5-year median for Intangibles is $7.9 million (2014), against an average of $7.9 million.
- The sharpest annual moves came in 2012 and 2016: Intangibles slipped 20.03% in 2012, then slumped 92.31% in 2016.
- Codexis' Intangibles stood at $12.9 million in 2012, then slipped by 26.09% to $9.6 million in 2013, then plunged by 35.29% to $6.2 million in 2014, then slumped by 54.54% to $2.8 million in 2015, then tumbled by 90.01% to $281000.0 in 2016.
- Business Quant data shows CDXS's Intangibles at $281000.0 in Q3 2016, $1.1 million in Q2 2016, and $2.0 million in Q1 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Codexis | 152.06 Mn | 97.14 Mn | 11.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | 281,000.00 |
| Jun 30, 2016 | 1.13 Mn |
| Mar 31, 2016 | 1.97 Mn |
| Dec 31, 2015 | 2.81 Mn |
| Sep 30, 2015 | 3.66 Mn |
| Jun 30, 2015 | 4.50 Mn |
| Mar 31, 2015 | 5.34 Mn |
| Dec 31, 2014 | 6.19 Mn |
| Sep 30, 2014 | 7.03 Mn |
| Jun 30, 2014 | 7.87 Mn |
| Mar 31, 2014 | 8.72 Mn |
| Dec 31, 2013 | 9.56 Mn |
| Sep 30, 2013 | 10.40 Mn |
| Jun 30, 2013 | 11.25 Mn |
| Mar 31, 2013 | 12.09 Mn |
| Dec 31, 2012 | 12.93 Mn |
| Sep 30, 2012 | 13.78 Mn |
| Jun 30, 2012 | 14.64 Mn |
| Mar 31, 2012 | 15.53 Mn |
| Dec 31, 2011 | 16.44 Mn |